More reads
- Are reasonable restraints on drug price increases doomed by pharma lobbying? (STAT)
- State’s biotech industry aims to spark girls’ interests in science long before high school. (Boston Globe)
- Investing in IPOs in Asia is not for faint of heart. (Bloomberg)
No hay comentarios:
Publicar un comentario